MedTrace Logo

Multiomics Study of Fibrosis Factors After Liver Transplantation and Exploration of Fibrosis Methylation Biomarkers

NCT05926778 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-07-03

No results posted yet for this study

Summary

This is a retrospective observational study in liver transplantation recipients with or without allograft liver fibrosis. Based on the GM-seq and Tcr-Seq data, a novel diagnostic model including DNA-methylation and TCR-Seq biomarkers will be established.

Conditions

  • Liver Fibrosis

Interventions

OTHER

Liver allograft fibrosis

Observational studies without intervention

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Qiang Xia, Prof. MD · Dept. Liver Surgery, Renji Hospital, School of Medicine, SJTU

  • Hao Feng, MD., Ph.D. · Dept. Liver Surgery, Renji Hospital, School of Medicine, SJTU

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-10-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05926778 on ClinicalTrials.gov